A Phase 3, Randomized, Multicenter, Allopurinol and Placebo-Controlled Study Assessing the Safety and Efficacy of Oral Febuxostat in Subjects With Gout.

Trial Profile

A Phase 3, Randomized, Multicenter, Allopurinol and Placebo-Controlled Study Assessing the Safety and Efficacy of Oral Febuxostat in Subjects With Gout.

Completed
Phase of Trial: Phase III

Latest Information Update: 05 Nov 2010

At a glance

  • Drugs Febuxostat (Primary) ; Allopurinol
  • Indications Gout; Hyperuricaemia
  • Focus Therapeutic Use
  • Acronyms APEX
  • Sponsors TAP Pharmaceutical Products
  • Most Recent Events

    • 05 Nov 2010 New trial record.
    • 01 Nov 2005 Results presented at the 69th Annual Scientific Meeting of the American College of Rheumatology and the 40th Annual Meeting of the Association of Rheumatology Health Professionals.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top